VN June 2024

Vetnews | Junie 2024 14 « BACK TO CONTENTS 10th WVA Global One Health Summit Held during WVAC2024 in Cape Town, South Africa The 10th WVA Global One Health Summit, themed “Coordinated & sustainable actions to contain AMR“, held during the 39th WVAC in Cape Town, South Africa, gathered key stakeholders including the tripartite, OHLEP, industry representatives, farmers, and IVSA students to address antimicrobial resistance (AMR) and mobilize stakeholders. The Summit emphasized the essential role of the animal health sector in responding to animal diseases while recognizing concerns about non-veterinary medical use of antimicrobials. Notable presentations were delivered by experts like Dr. Moetapele Letshwenyo, WOAH Regional Representative, highlighting the need for coordination in antimicrobial use, and Dr. Joseph Wamala, WHO Regional Representative, who outlined the urgency of addressing AMR. Dr. Kofi Afakye presented FAO’s perspective on addressing AMR in the agri-food sector, while Dr. Olatunji Nasir, Chair of the Pharmaceutical Stewardship Working Group, presented on the Brooke and WVA Essential Veterinary Medicines List emphasized the pivotal role of veterinary medicines in tackling AMR. Dr. Wanda Markotter, Co-chair of OHHLEP, discussed the OH JPA’s alignment with other plans, stressing the importance of political commitment and practical guidance. Dr. Ellen van Nierop, WSAVA President, emphasized the need to reduce medication reliance through proper care and raised the question of whether incentives or enforcement measures would be more effective in driving changes. Finally, industry and farmer perspectives were shared by Dr. Marc Prikazsky, CEVA Chief Executive Officer and Dr. Theo de Jager, Former President of WFO, respectively. Following the presentations, a panel discussion, bringing together experts to synthesize key insights and propose actionable steps to combat AMR. Emphasizing the One Health approach, participants stressed the importance of cross-sector collaboration across human, animal, and environmental health domains. Access to medicines and prevention strategies emerged as critical focal points, highlighting the need to ensure the availability of essential medications while promoting responsible usage. Concrete actions were identified as imperative in addressing AMR effectively, including surveillance initiatives and capacity-building efforts. Moreover, education emerged as a cornerstone in raising awareness and fostering behavioural change to combat AMR. These discussions echoed the recommendations of the Antimicrobial Resistance Multi-Stakeholder Partnership Platform, endorsed by WVA, signifying a unified commitment to tackling the escalating threat of AMR comprehensively. v >>> 15 >>> 15

RkJQdWJsaXNoZXIy OTc5MDU=